Drug discovery for autism spectrum disorder: challenges and opportunities

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nature reviews. Drug discovery

• Publication date

  2013-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrd4102PMID 24080699
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders

  2013cited by this paper
• In utero exposure to valproic acid and autism--a current review of clinical and animal studies.

  2013cited by this paper
• Randomized, Controlled, Phase 2 Trial of STX209 (Arbaclofen) for Social Function in ASD

  2013cited by this paper
• A Randomized Double-Blind, Placebo-Controlled Trial of Minocycline in Children and Adolescents with Fragile X Syndrome

  2013cited by this paper
• The Innovative Medicines Initiative: A European Response to the Innovation Challenge

  2012cited by this paper
• Improving R&D productivity of pharmaceutical companies through public–private partnership: experiences from the Innovative Medicines Initiative

  2012cited by this paper
• Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders.

  2012cited by this paper
• Whole-genome sequencing in autism identifies hot spots for de novo germline mutation.

  2012cited by this paper
• Rare and common variants: twenty arguments

  2012cited by this paper
• STRING v9.1: protein-protein interaction networks, with increased coverage and integration

  2012cited by this paper
• Detection and characterization of copy number variation in autism spectrum disorder.

  2012cited by this paper
• A travel guide to Cytoscape plugins

  2012cited by this paper
• Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.

  2012cited by this paper
• Common genetic variants, acting additively, are a major source of risk for autism

  2012cited by this paper
• Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008

  2012cited by this paper
• Phenotypic heterogeneity of genomic disorders and rare copy-number variants.

  2012cited by this paper
• Negative Allosteric Modulation of the mGluR5 Receptor Reduces Repetitive Behaviors and Rescues Social Deficits in Mouse Models of Autism

  2012cited by this paper
• Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome.

  2012cited by this paper
• Cellular and synaptic network defects in autism.

  2012cited by this paper
• EU-AIMS: a boost to autism research

  2012cited by this paper
• Translational animal models of autism and neurodevelopmental disorders

  2012cited by this paper
• Patterns and rates of exonic de novo mutations in autism spectrum disorders

  2012cited by this paper
• Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABAB Receptors with Arbaclofen

  2012cited by this paper
• Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial

  2012cited by this paper
• Comprehensive Analysis of Ultrasonic Vocalizations in a Mouse Model of Fragile X Syndrome Reveals Limited, Call Type Specific Deficits

  2012cited by this paper
• Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome

  2012cited by this paper
• Rate of de novo mutations and the importance of father’s age to disease risk

  2012cited by this paper
• Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.

  2012cited by this paper
• Human neuroimaging of oxytocin and vasopressin in social cognition.

  2012cited by this paper
• Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes.

  2011cited by this paper
• Fragile X Syndrome: The GABAergic System and Circuit Dysfunction

  2011cited by this paper
• Mutations causing syndromic autism define an axis of synaptic pathophysiology

  2011cited by this paper
• Using iPS cell-derived neurons to uncover cellular phenotypes associated with Timothy Syndrome

  2011cited by this paper
• An autism‐associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor‐mediated synaptic transmission in hippocampus

  2011cited by this paper
• The Genetics of Autism Spectrum Disorders

  2011cited by this paper
• FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.

  2011cited by this paper
• Autism spectrum disorders and autistic traits: A decade of new twin studies

  2011cited by this paper
• Research review: Constraining heterogeneity: the social brain and its development in autism spectrum disorder.

  2011cited by this paper
• Toward fulfilling the promise of molecular medicine in fragile X syndrome.

  2011cited by this paper
• Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease

  2011cited by this paper
• Reliability of Eye Tracking and Pupillometry Measures in Individuals with Fragile X Syndrome

  2011cited by this paper
• Investigating synapse formation and function using human pluripotent stem cell-derived neurons

  2011cited by this paper
• Epigenetic discordance at imprinting control regions in twins.

  2011cited by this paper
• Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting.

  2011cited by this paper
• Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial

  2011cited by this paper
• Psychometric Study of the Aberrant Behavior Checklist in Fragile X Syndrome and Implications for Targeted Treatment

  2011cited by this paper
• Genetic and epigenetic networks in intellectual disabilities.

  2011cited by this paper
• Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function

  2011cited by this paper
• Unusual repertoire of vocalizations in adult BTBR T+tf/J mice during three types of social encounters

  2011cited by this paper
• Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056

  2011cited by this paper
• GSK3 signalling in neural development

  2010cited by this paper
• Open-label add-on treatment trial of minocycline in fragile X syndrome

  2010cited by this paper
• Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome.

  2010cited by this paper
• A Randomized Controlled, Phase 2 Trial of the Viral Serpin Serp-1 in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

  2010cited by this paper
• Behavioural phenotyping assays for mouse models of autism

  2010cited by this paper
• Promoting social behavior with oxytocin in high-functioning autism spectrum disorders

  2010cited by this paper
• Comorbid Psychiatric Disorders Associated with Asperger Syndrome/High-functioning Autism: A Community- and Clinic-based Study

  2010cited by this paper
• Innovation in Residency Education and Evolving Pediatric Health Needs

  2010cited by this paper
• Sensory features and repetitive behaviors in children with autism and developmental delays

  2010cited by this paper
• Altered ultrasonic vocalizations in a tuberous sclerosis mouse model of autism

  2010cited by this paper
• Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report

  2010cited by this paper
• GSK3 Influences Social Preference and Anxiety-Related Behaviors during Social Interaction in a Mouse Model of Fragile X Syndrome and Autism

  2010cited by this paper
• A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells.

  2010cited by this paper
• Network medicine: a network-based approach to human disease

  2010cited by this paper
• Epidemiology of Pervasive Developmental Disorders

  2009cited by this paper
• Fragile X syndrome -- from genes to cognition.

  2009cited by this paper
• Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice

  2009cited by this paper
• Finding the missing heritability of complex diseases

  2009cited by this paper
• The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders.

  2009cited by this paper
• Genetics of autism spectrum disorders

  2009cited by this paper
• Genome-wide association studies for complex traits: consensus, uncertainty and challenges

  2008cited by this paper
• Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function

  2008cited by this paper
• Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons

  2008cited by this paper
• Autism‐like behavioral phenotypes in BTBR T+tf/J mice

  2008cited by this paper
• Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.

  2008cited by this paper
• The autistic neuron: troubled translation?

  2008cited by this paper
• Open-Label Treatment Trial of Lithium to Target the Underlying Defect in Fragile X Syndrome

  2008cited by this paper
• Tuberous sclerosis

  2008cited by this paper
• Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model

  2008cited by this paper
• Regression in Autistic Spectrum Disorders

  2008cited by this paper
• Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis

  2008cited by this paper
• Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample.

  2008cited by this paper
• A Mouse Model of Tuberous Sclerosis: Neuronal Loss of Tsc1 Causes Dysplastic and Ectopic Neurons, Reduced Myelination, Seizure Activity, and Limited Survival

  2007cited by this paper
• Correction of fragile X syndrome in mice.

  2007cited by this paper
• Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005.

  2006cited by this paper
• Pervasive developmental disorders in preschool children: confirmation of high prevalence.

  2005cited by this paper
• Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2

  2005cited by this paper
• The factor structure of autistic traits.

  2004cited by this paper
• Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1

  2002cited by this paper
• Tuberous sclerosis.

  1994cited by this paper
• Consensus Report

  1985cited by this paper
• Autistic disturbances of affective contact.

  1968cited by this paper

• Nanosensor-based method for autism diagnosis using nitric oxide from patient-derived induced pluripotent stem cells as a biomarker

  2026cites this paper
• Using the cognitive rigidity-flexibility dimension to deepen our understanding of the autism spectrum

  2025cites this paper
• Nitric oxide and peroxynitrite as new biomarkers for early diagnosis of autism.

  2025cites this paper
• Beyond the Magic Pill: Reassessing the Role of Pharmacology in Autism Care through Restorative Perspectives

  2025cites this paper
• The Neuroimmunology of Autism

  2025cites this paper
• Autism and α7-nicotinic acetylcholine receptors: new pharmacological and herbal interventions

  2025cites this paper
• Recovery of centralities in medial prefrontal and sensory-related cortices associated with social behavior improvements in an autism mouse model

  2025cites this paper
• Microbiota-based therapies as novel targets for autism spectrum disorder: A systematic review and meta-analysis.

  2025cites this paper
• Establishment of a standardized daily behavior collection and analysis system for brain disease models of rhesus and cynomolgus monkeys and its application in autism spectrum disorder

  2024cites this paper
• Treatment options in autism with epilepsy

  2024cites this paper
• Retracing our steps: A review on autism research in children, its limitation and impending pharmacological interventions.

  2023cites this paper
• A platform trial approach to proof-of-concept (POC) studies in autism spectrum disorder: Autism spectrum POC initiative (ASPI)

  2023cites this paper
• Editorial: Precision medicine approaches for heterogeneous conditions such as autism spectrum disorders (The need for a biomarker exploration phase in clinical trials - Phase 2m)

  2023cites this paper
• Exploratory analysis of L1 retrotransposons expression in autism

  2023cites this paper
• Anti-apoptotic capacity of MALAT1 on hippocampal neurons correlates with CASP3 DNA methylation in a mouse model of autism

  2023cites this paper
• Autism and associated disorders: cannabis as a potential therapy.

  2022cites this paper
• Pharmacophore modeling, molecular docking, and molecular dynamics studies to identify new 5-HT_2AR antagonists with the potential for design of new atypical antipsychotics

  2022cites this paper
• A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder

  2022cites this paper
• Rol de la terapia farmacológica en los trastornos del espectro autista

  2022cites this paper
• Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications

  2022cites this paper
• The Autism Impact Measure (AIM): Meaningful Change Thresholds and Core Symptom Changes Over One Year from an Online Survey in the U.S.

  2022cites this paper
• Maternal separation induces autism spectrum disorder in young rhesus monkeys

  2022cites this paper
• Two neuroanatomical subtypes of males with autism spectrum disorder revealed using semi-supervised machine learning

  2022cites this paper
• Autism and Emotion: A Narrative Review

  2021cites this paper
• Advancing models of neural development with biomaterials

  2021cites this paper
• Kv1.1 deficiency alters repetitive and social behaviors in mice and rescues autistic‐like behaviors due to Scn2a haploinsufficiency

  2021cites this paper
• Autism and mood disorders

  2021cites this paper
• A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders.

  2021cites this paper
• Oxytocin normalizes altered circuit connectivity for social rescue of the Cntnap2 knockout mouse.

  2021cites this paper
• The effect of fecal microbiota transplantation on autistic-like behaviors in Fmr1 KO mice.

  2020cites this paper
• Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder

  2020cites this paper
• Dosage-sensitive genes in autism spectrum disorders: From neurobiology to therapy.

  2020cites this paper
• Prevention and early intervention in youth mental health: is it time for a multidisciplinary and trans-diagnostic model for care?

  2020cites this paper
• How can preclinical cognitive research further neuropsychiatric drug discovery? Chances and challenges

  2020cites this paper
• Autism spectrum disorder

  2020cites this paper
• P2X7 Receptors Drive Poly(I:C) Induced Autism-like Behavior in Mice

  2019cites this paper
• Autism-associated protein kinase D2 regulates embryonic cortical neuron development.

  2019cites this paper
• Neurodevelopmental roles and the serotonin hypothesis of autism spectrum disorder

  2019cites this paper
• mGlu5-mediated signalling in developing astrocyte and the pathogenesis of autism spectrum disorders.

  2018cites this paper
• SAP97 regulates behavior and expression of schizophrenia risk enriched gene sets in mouse hippocampus

  2018cites this paper
• A comparative study of the genetic components of three subcategories of autism spectrum disorder

  2018cites this paper
• Glutamate and GABA in autism spectrum disorder—a translational magnetic resonance spectroscopy study in man and rodent models

  2018cites this paper
• Effects of 5-HT1A Receptor Agonism on Repetitive Grooming and Learning Behavior in Shank3B Mice

  2018cites this paper
• Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology

  2018influential citation
• Multidimensional Neuroanatomical Subtyping of Autism Spectrum Disorder

  2018cites this paper
• Progress in the genetics of autism spectrum disorder

  2018cites this paper
• Caregiver Daily Reporting of Symptoms in Autism Spectrum Disorder: Observational Study Using Web and Mobile Apps

  2018cites this paper
• Disparities in Utilization of Therapy and Educational Services for Children With Autism Spectrum Disorder

  2018cites this paper
• Platelets as a surrogate disease model of neurodevelopmental disorders: Insights from Fragile X Syndrome

  2018cites this paper
• p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse

  2018cites this paper
• Dysregulation of autism-associated synaptic proteins by psychoactive pharmaceuticals at environmental concentrations.

  2017cites this paper
• Repository of the Radboud

  2017cites this paper
• Human induced pluripotent stem cells for modelling neurodevelopmental disorders

  2017cites this paper
• JAKE® Multimodal Data Capture System: Insights from an Observational Study of Autism Spectrum Disorder

  2017cites this paper
• Defining the hidden evidence in autism research. Forty per cent of rigorously designed clinical trials remain unpublished ‐ a cross‐sectional analysis

  2017cites this paper
• Treating a novel plasticity defect rescues episodic memory in Fragile X model mice

  2017cites this paper
• Autism Behavior Inventory: A Novel Tool for Assessing Core and Associated Symptoms of Autism Spectrum Disorder

  2017cites this paper
• Aligning physiology with psychology: Translational neuroscience in neuropsychiatric drug discovery

  2017cites this paper
• Pivotal Response Treatment for autism spectrum disorder (ASD)

  2017cites this paper
• Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue

  2016cites this paper
• AMP: A platform for managing and mining data in the treatment of Autism Spectrum Disorder.

  2016cites this paper
• Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism

  2016cites this paper
• Human Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies

  2016cites this paper
• Impairments in dendrite morphogenesis as etiology for neurodevelopmental disorders and implications for therapeutic treatments.

  2016cites this paper
• Altering the course of schizophrenia: progress and perspectives

  2016cites this paper
• Brain Fires in Autism Spectrum Disorders

  2016cites this paper
• Pharmacogenomic Study Reveals New Variants of Drug Metabolizing Enzyme and Transporter Genes Associated with Steady-State Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Thai Autism Spectrum Disorder Patients

  2016cites this paper
• Phenotyping, Etiological Factors, and Biomarkers: Toward Precision Medicine in Autism Spectrum Disorders

  2016cites this paper
• Improving treatment of neurodevelopmental disorders: recommendations based on preclinical studies

  2016cites this paper
• AMP: A platform for managing and mining data in the treatment of Autism Spectrum Disorder

  2016cites this paper
• Psychoactive pharmaceuticals at environmental concentrations induce in vitro gene expression associated with neurological disorders

  2016cites this paper
• Caregiver Preferences for the Treatment of Males with Fragile X Syndrome

  2016cites this paper
• Autism Spectrum Disorder: Genes to Pathways to Circuits

  2016cites this paper
• Critical periods and neurodevelopmental brain disorders

  2016cites this paper
• Idiopathic Autism: Cellular and Molecular Phenotypes in Pluripotent Stem Cell-Derived Neurons

  2016cites this paper
• Genetic influences on social attention in free-ranging rhesus macaques.

  2015cites this paper
• The balancing act of GABAergic synapse organizers.

  2015cites this paper
• Pharmacogenomic Medicine in Autism: Challenges and Opportunities

  2015cites this paper
• Fragile X disappointments upset autism ambitions

  2015cites this paper
• Oxytocin: Parallel Processing in the Social Brain?

  2015cites this paper
• Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives.

  2015cites this paper
• Structural-functional connectivity deficits of neocortical circuits in the Fmr1−/y mouse model of autism

  2015cites this paper
• Translational Approaches to Autism Spectrum Disorder

  2015cites this paper
• Modeling autism-relevant behavioral phenotypes in rats and mice: Do ‘autistic’ rodents exist?

  2015cites this paper
• Trans-synaptic zinc mobilization improves social interaction in two mouse models of autism through NMDAR activation

  2015cites this paper
• The complex genetics in autism spectrum disorders

  2015cites this paper
• GABAergic neurotransmission alterations in autism spectrum disorders

  2015cites this paper
• Shared functional defect in IP3R-mediated calcium signaling in diverse monogenic autism syndromes

  2015cites this paper
• Identification and validation of biomarkers for autism spectrum disorders

  2015cites this paper
• From de novo mutations to personalized therapeutic interventions in autism.

  2015cites this paper
• The Genetic Basis of Autism Spectrum Disorder

  2015cites this paper
• Cognitive disorders: Deep brain stimulation for Rett syndrome

  2015cites this paper
• Psychoactive pharmaceuticals as environmental contaminants may disrupt highly inter-connected nodes in an Autism-associated protein-protein interaction network

  2015cites this paper
• Copy Number Variation in Neurodevelopmental Disorders

  2014cites this paper
• Neuregulin 1-Induced AKT and ERK Phosphorylation in Patients with Fragile X Syndrome (FXS) and Intellectual Disability Associated with Obstetric Complications

  2014cites this paper
• Elucidating the Role of Neurotensin in the Pathophysiology and Management of Major Mental Disorders

  2014cites this paper
• Mesenchymal stem cells in treating autism: Novel insights.

  2014cites this paper
• Subchronic Treatment of Donepezil Rescues Impaired Social, Hyperactive, and Stereotypic Behavior in Valproic Acid-Induced Animal Model of Autism

  2014cites this paper
• Adaptive Maternal Immune Deviations as a Ground For Autism Spectrum Disorders Development in Children

  2014cites this paper
• Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders and tail-chasing Bull Terriers with a phenotype similar to autism

  2014cites this paper